Ten Years of Experience with Biphasic Insulin Aspart 30: From Drug Development to the Latest Clinical Findings

ISSN： 0012-6667

Source： Drugs, Vol.72, Iss.11, 2012-07, pp. : 1495-1520

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biphasic insulin aspart 30 for the treatment of type 1 diabetes mellitus

By Velásquez-Mieyer Pedro A Neira Claudia P

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 13, 2008-09 ,pp. : 2377-2382

Informa Healthcare

Access to resources Recommend Favorite

Insulin aspart plus insulin protamine aspart [biphasic insulin aspart 30] may improve glycaemic control in patients with type 2 diabetes mellitus

Inpharma, Vol. 1, Iss. 1628, 2008-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Biphasic insulin aspart lifesaving and cost saving in Sweden

Inpharma, Vol. 1, Iss. 1647, 2008-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Clinical Pharmacokinetics and Pharmacodynamics of Insulin Aspart

By Lindholm A.

Clinical Pharmacokinetics, Vol. 40, Iss. 9, 2001-01 ,pp. : 641-659

Adis International

Access to resources Recommend Favorite

Biphasic insulin aspart in the treatment of type 2 diabetes mellitus

By Cucinotta Domenico Russo Giuseppina T

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 17, 2009-12 ,pp. : 2905-2911

Informa Healthcare

Access to resources Recommend Favorite